Delivery Order SPE2DB20D1100-SPE2DB25FC3C8
Award Date
5/13/25
Potential Completion Date
5/14/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,533.01 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,214,562 units of the pharmaceutical drug Ondansetron HCL 4 mg Tablet in 500 count packages. The contract has a firm fixed-price pricing structure and an ultimate completion date of July 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award, which is part of a larger indefinite delivery contract with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,566,166,114 units of Ondansetron HCL 4 mg tablets, with a ceiling value of $15,834.86 and a completion date of October 22, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $16,658.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,600 units of the prescription drug Ondansetron HCL 4mg Tablet. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for supplying a wide range of pharmaceutical and medical supplies to support military treatment programs...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the delivery of 4,564,351 units of the drug Ondansetron HCl 4 mg tablet. The total ceiling value of the contract is $3,730.98, with an ultimate completion date of April 23, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,730.72 firm-fixed-price contract is for the delivery of 4,568,076 units of the medication Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of April 30, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award for $11,013.52 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,198,277 units of Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order that will run through February 7, 2025. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award, which does not have a set-aside designation. The company also holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,464.39, is for the delivery of 4,564,861,520 units of the drug ondansetron HCL 4 mg tablets. The contract is structured as a Firm Fixed Price Delivery Order, with a completion date of June 11, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,093 units of the prescription medication Ondansetron HCL 4 mg tablet. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,606.01 and a period of performance through May 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,108,585 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $20,428.34 and a completion date of March 29, 2024. AmerisourceBergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,830.41, is for the delivery of 4,566,407,695 units of Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of November 13, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery...